Latest Updates
-
Amitabh Bachchan's Misunderstood Blog Sparked Concern, But His Real Medical Battles Define Resilience -
Jaipur Ranks 6th Among World's Happiest Cities 2026: The Culture Behind The Joy -
Why Green Is the Colour of Sawan: History, Symbolism, and Styling Tips -
Legionnaires' Disease Outbreak: What It Is, Symptoms, Causes, And Prevention Explained -
Ananya Panday's Gaurav Gupta Couture Featured 12,000 Pearls, 2,600 Petals And A Celestial Love Story -
Kharchi Puja 2026: Tripura's Ancient Festival Where The Heads Of Fourteen Deities Are Worshipped -
World Brain Day 2026: How Quality Sleep Helps Safeguard Your Brain Health -
National Mango Day 2026: Why Mango Is Called The 'King Of Fruits' And What Sets It Apart -
Is It Monsoon Hair Fall Or Something More Serious? How To Tell -
World Brain Day 2026: Date, History, Theme, and Why It Matters
Now, Multicolour MRIs To Improve Disease Detection
Read to know about multicolour MRIs to improve disease detection.
Scientists have developed a new method to make magnetic resonance imaging (MRI) multicolour to improve disease detection. Current MRI techniques rely on a single contrast agent injected into a patient's veins to vivify images. The new method uses two agents at once, which could allow doctors to map multiple characteristics of a patient's internal organs in a single MRI.

"The method we developed enables, for the first time, the simultaneous detection of two different MRI contrast agents," said Chris Flask, associate professor at Case Western Reserve University School of Medicine in the US. Two contrast agents could include one specifically targeting diseased tissue, and one designed to show healthy tissue, for example.
The new method would enable immediate comparisons of how each agent distributes in the same patient. "This multi-agent detection capability has the potential to transform molecular imaging, as it provides a critical translational pathway for studies in patients," said Flask. "It also provides a unique imaging platform to rigorously study molecular therapies," he said.
Therapies could include those targeting biomarkers or other detectable molecules associated with diseases. Two contrast agents, gadolinium and manganese, can be detected and independently quantified during MRIs, researchers said.

The results provide "an adaptable, quantitative imaging framework to assess two MRI contrast agents simultaneously for a wide variety of imaging applications," they said. The researchers have begun to investigate widespread practical applications for the new MRI approach.
"We validated our new methodology, opening the possibility for numerous follow-on application studies in cancer, genetic diseases such as cystic fibrosis, and metabolic diseases such as diabetes," Flask added. The research was published in the journal Scientific Reports.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications